Article
TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease
1 Sept 2017
Abstract excerpt
Michael N. Hall is this year's recipient of the Lasker Basic Medical Research Award for the identification of the target of rapamycin, TOR. TOR is a master regulator of the cell's growth and metabolic state, and its dysregulation contributes to a variety of diseases, including diabetes, obesity, neurodegenerative disorders, aging, and cancer, making the TOR pathway an attractive therapeutic target.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
